Literature DB >> 21115267

Risk charts to identify low and excessive responders among first-cycle IVF/ICSI standard patients.

N la Cour Freiesleben1, T A Gerds, J L Forman, J D Silver, A Nyboe Andersen, B Popovic-Todorovic.   

Abstract

Ovarian stimulation carries a risk of either low or excessive ovarian response. The aim was to develop prognostic models for identification of standard (ovulatory and normal basal FSH) patients’ risks of low and excessive response to conventional stimulation for IVF/intracytoplasmic sperm injection. Prospectively collected data on 276 first-cycle patients treated with 150 IU recombinant FSH (rFSH)/day in a long agonist protocol were analysed. Logistic regression analysis was applied to the outcome variables:low (seven or less follicles) and excessive (20 or more follicles) response. Variables were woman’s age, menstrual cycle length, weight or body mass index, ovarian volume, antral follicle count (AFC) and basal FSH. The predictive performance of the models was evaluated from the prediction error (Brier score, %) where zero corresponds to a perfect prediction. Model stability was assessed using 1000 bootstrap cross-validation steps. The best prognostic model to predict low response included AFC and age (Brier score 7.94) and the best model to predict excessive response included AFC and cycle length (Brier score 15.82). Charts were developed to identify risks of low and excessive ovarian response. They can be used for evidence-based risk assessment before ovarian stimulation and may assist clinicians in individual dosage of their patients.
Copyright © 2010 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115267     DOI: 10.1016/j.rbmo.2010.08.010

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  4 in total

1.  The Brier score does not evaluate the clinical utility of diagnostic tests or prediction models.

Authors:  Melissa Assel; Daniel D Sjoberg; Andrew J Vickers
Journal:  Diagn Progn Res       Date:  2017-12-02

2.  A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study.

Authors:  Bum Chae Choi; Canquan Zhou; Hong Ye; Yun Sun; Ying Zhong; Fei Gong; Ivan Sini; Nadezda Abramova; Salvatore Longobardi; Miranda Hickey; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2022-01-17       Impact factor: 5.211

3.  Association Between the Ratio of Ovarian Stimulation Duration to Original Follicular Phase Length and In Vitro Fertilization Outcomes: A Novel Index to Optimise Clinical Trigger Time.

Authors:  Xinyang Zhao; Xu Zhang; Shanshan Wu; Jichun Tan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-25       Impact factor: 6.055

4.  A new ovarian response prediction index (ORPI): implications for individualised controlled ovarian stimulation.

Authors:  Joao Batista A Oliveira; Ricardo L R Baruffi; Claudia G Petersen; Ana L Mauri; Adriana M Nascimento; Laura Vagnini; Juliana Ricci; Mario Cavagna; Jose G Franco
Journal:  Reprod Biol Endocrinol       Date:  2012-11-21       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.